choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Novartis IPO

Novartis IPO Newsletter
  • Evommune nabs $150M in IPO amid federal shutdown 06 Nov 2025 05:41 GMT

    … , priced a $150 million initial public offering on Wednesday. The Palo Alto … a newly approved therapy from Novartis, is associated with certain side … , afterwards.  Prior to its IPO, Evommune had raised $267 … two dozen that had priced IPOs by this time last …

  • Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter 28 Oct 2025 13:20 GMT

    … . Analysts polled by FactSet expected Novartis to earn $2.27 a … . During the year-earlier period, Novartis earned $2.06 per share … -point hit on Entresto sales, Novartis said in its news release … To Buy And Watch: Top IPOs, Big And Small Caps, Growth …

  • USA Rare Earth, Iren, Novartis, Softbank: Trending Stocks 27 Oct 2025 12:38 GMT

    … might be preparing for an IPO there. 01:21 Speaker A … :26 Speaker A Swiss giant Novartis is making a big move … neuroscience. 01:41 Speaker A Novartis shares are slightly lower this …

  • In Novartis patent case, India has a BIT of cover 22 Sep 2025 18:35 GMT

    … Office (IPO) has revoked the patent of Novartis for … market, benefiting patients. Novartis may challenge this revocation … having jurisdiction, if Novartis challenges this patent revocation … expectations. So, could Novartis have the legitimate expectation …

  • Novartis Loses India Patent on Heart Failure Drug Vymada 19 Sep 2025 04:56 GMT

    … Also Read:Interim relief to Novartis: Delhi HC reinstates Entresto … its order, the IPO noted that Novartis had failed to … and Eris Lifesciences following Novartis’ lawsuits. Several firms had … also noted that while Novartis’ earlier sacubitril–valsartan patent …

  • Novartis dives deeper into protein degraders with second Monte Rosa deal 15 Sep 2025 17:47 GMT

    … and early testing before Novartis takes over development for … following a $222 million initial public offering in 2021. Monte Rosa … as traditional drugs do. Novartis has been particularly active … of biomedical research at Novartis, in a statement. Marshall …

  • Patent Office Revokes Patent for Novartis’ Cardiac Drug 17 Sep 2025 13:24 GMT

    … but courts restrained them following Novartis’ legal action. With the … enhanced therapeutic efficacy. Notably, Novartis had earlier lost its patent … under the same clause. IPO’s Ruling Usha Rao, … efficacy.” High Stakes for Novartis Vymada is a major revenue …

  • SIJ Acroni, Novartis and national chemistry institute among leading innovators 17 Sep 2025 12:10 GMT

    Pharma companies Novartis, Krka and Lek, the National … SMARTI iCon wood scanner. Iskra Ipo received the gold award for … in drinking and bathing waters. Novartis and Keko - Oprema also …

  • Why India revoked patent of Novartis’ cardiac drug and why it matters 16 Sep 2025 18:36 GMT

    … revoked the patent on Novartis’ cardiac drug Entresto, sold … , opposed the patent on Novartis’ heart-failure drug Vymada. … The Indian Pharmaceutical Alliance opposed Novartis’ patent on Vymada. File … the IPO’s decision in court. “The patentee (Novartis) abstained …

  • In major move, patent of Novartis' blockbuster cardiac drug revoked by India 16 Sep 2025 07:35 GMT

    … Patent Office (IPO) has revoked the patent on Novartis’ blockbuster therapy … and heart failure. For Novartis, the drug is a … access to affordable medicines. Novartis’ patent, filed in 2007 … Legal observers noted that Novartis abstained from the final …

Satisfied with the content?

Continue to create your account.